Hydrochloric Acid

Hydrochloric Acid

SCHEMBL29244

CCCCCCCCCCc1ccccc1C(C)(C)N.Cl

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 known ✓ P21453 2/20 0.41
PPARG known ✓ P37231 1/20 0.40
LIPG Q9Y5X9 1/20 0.50
NR1H2 P55055 1/20 0.42
NR1H3 Q13133 1/20 0.42
CYSLTR2 Q9NS75 4/20 0.41
CYSLTR1 Q9Y271 4/20 0.41
BID P55957 3/20 0.40
MCL1 Q07820 3/20 0.40
BCL2L1 Q07817 2/20 0.40
BAK1 Q16611 2/20 0.40
KAT8 Q9H7Z6 2/20 0.40
TLR8 Q9NR97 1/20 0.40
PPARA Q07869 1/20 0.40
EP300 Q09472 1/20 0.40
KAT2A Q92830 1/20 0.40
KAT2B Q92831 1/20 0.40
KAT5 Q92993 1/20 0.40
SAE1 Q9UBE0 1/20 0.40
THRA P10827 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6365533 1.00 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
Hydrochloric Acid SCHEMBL108306 1.00 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
Hydrochloric Acid SCHEMBL127365 1.00 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
Hydrochloric Acid SCHEMBL7630157 1.00 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
Hydrochloric Acid SCHEMBL7632464 1.00 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
Hydrochloric Acid SCHEMBL28966 1.00 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
Hydrochloric Acid SCHEMBL7636984 1.00 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
Hydrochloric Acid SCHEMBL7637101 1.00 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
Hydrochloric Acid SCHEMBL7633346 1.00 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1
Hydrochloric Acid SCHEMBL526177 1.00 LIPG (0.50) LIPGNR1H2NR1H3CYSLTR2CYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1534 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4701612-A1 HAIR TREATMENT COMPOSITIONS Unilever IP Holdings B.V. (NL) 2026-03-04 EP claimed
US-12458574-B2 Deposition system for hair CONOPCO, INC. (US) 2025-11-04 US claimed
US-12447118-B2 Hair treatment compositions CONOPCO, INC. (US) 2025-10-21 US claimed
CN-119898789-A Flower-like sphere mordenite as well as preparation method and application thereof 中国石油化工股份有限公司 2025-04-29 CN claimed
US-12280131-B2 Deposition system for hair CONOPCO, INC. (US) 2025-04-22 US claimed
WO-2025073624-A1 HAIR STRAIGHTENING COMPOSITIONS AND METHODS OF USING THEREOF UNILEVER IP HOLDINGS B.V. (NL) 2025-04-10 WO claimed
WO-2024223432-A1 HAIR TREATMENT COMPOSITIONS UNILEVER IP HOLDINGS B.V. (NL) 2024-10-31 WO claimed
US-12076432-B2 Method of repairing oxidatively treated hair CONOPCO, INC. (US) 2024-09-03 US claimed
US-20180087006-A1 CLEANING SOLUTION AND CLEANING METHOD FOR MATERIAL COMPRISING CARBON-INCORPORATED SILICON OXIDE FOR USE IN RECYCLING WAFER MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2018-03-29 US claimed
EP-3285285-A1 CLEANING LIQUID FOR MATERIAL COMPRISING CARBON-CONTAINING SILICON OXIDE FOR WAFER RECYCLING, AND CLEANING METHOD Mitsubishi Gas Chemical Company, Inc. (JP) 2018-02-21 EP claimed
US-9889079-B2 Process for making a conditioning gel phase CONOPCO, INC. (US) 2018-02-13 US claimed
US-9295859-B2 Porous, dissolvable solid substrate and surface resident coating comprising matrix microspheres THE PROCTER & GAMBLE COMPANY (US) 2016-03-29 US claimed
WO-2013131756-A2 HAIR CARE COMPOSITION UNILEVER PLC (GB) 2013-09-12 WO claimed
EP-1434554-B1 HAIR TREATMENT COMPOSITIONS WHICH PROVIDE HAIR BODY AND WHICH COMPRISE SILICONE PRESSURE SENSITIVE ADHESIVES UNILEVER PLC (GB) 2011-05-11 EP claimed
US-20060140888-A1 Whitening agent containing crystalline molecular complex of hydroquinone and surfactant CIRCLE FOR THE PROMOTION OF SCIENCE AND ENGINEERING, THE (JP) 2006-06-29 US claimed
US-6787130-B2 AQUEOUS SOLUTIONS CONTAINING HAIR CONDITIONER, CLEANING COMPOUND AND SUSPENSION AGENT; RINSABLE UNILEVER HOME & PERSONAL CARE USA A DIVISION OF CONOPCO, INC. 2004-09-07 US claimed
EP-1434554-A1 HAIR TREATMENT COMPOSITIONS WHICH PROVIDE HAIR BODY AND WHICH COMPRISE SILICONE PRESSURE SENSITIVE ADHESIVES UNILEVER PLC (GB) 2004-07-07 EP claimed
US-20030091523-A1 Hair treatment compositions which provide hair body and which comprise silicone pressure sensitive adhesives UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. 2003-05-15 US claimed
WO-2003028677-A1 HAIR TREATMENT COMPOSITIONS WHICH PROVIDE HAIR BODY AND WHICH COMPRISE SILICONE PRESSURE SENSITIVE ADHESIVES UNILEVER PLC (GB) 2003-04-10 WO claimed
WO-2001085112-A2 SHAVING CREAM FORMULATIONS AUSTRALIAN IMPORTERS, LTD. (US) 2001-11-15 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12280131-B2 Deposition system for hair PRDX5, DECR2, PLIN3 S1PR1 177/4885PPARG 25/4885LIPG 3987/4885
US-12447118-B2 Hair treatment compositions SLC25A1, OAT, OTC S1PR1 1486/4885PPARG 2347/4885LIPG 4433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.